chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a female child who on 02/06/2001 was vaccinated with varicella vaccine. Subsequently, the pt developed chicken pox with approx. 50 lesions. The pt sought medical attention. The registered nurse also discussed the experience of two other children after vaccinated with varicella vaccine. Additional info has been requested.
As per mom, symptoms started two days after receiving 1st flu vaccine.  Mom states she took child to hospital on 11/16/08.
I got a fever during the night after the third dose. The next day the fever had come down but I was very tired all day. In the evening after I finished dinner I fainted, I was out briefly. Then the Ambulance came and took me to the hospital, I was conscious and sweating profusely. All tests results were normal, except my white blood cell count was slightly elevated. I was given 2 Liters of saline and discharged. I felt fine later and I have not had really had any other problems. My vaccine was a full dose of Moderna.
I experienced the sudden onset of dizziness, hot and cold chills, and nausea. I felt strange and decided to retire for the night.
BLOOD CLOT; COPD; SICK; PULMONARY HYPERTENSION; This spontaneous report received from a patient concerned a 74 year old female. The patient's weight was 184 pounds, and height was 64 inches. The patient's concurrent conditions included: sulfa drug allergy, egg allergy, tuberculosis test allergy, abstains from alcohol, and non-smoker, and other pre-existing medical conditions included: Patient was not pregnant at the time of reporting. There was no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A expiry: UNKNOWN) dose was not reported, 1 total administered at right arm on 02-JUN-2021 for covid-19 prophylaxis. Age at time of vaccination 73 years old. No concomitant medications were reported.  Patient had the shot and then started to get sick on an unspecified date in 2022 and was still having issues. On an unspecified date in 2022, the patient was diagnosed with pulmonary hypertension. Patient reported that she was in the hospital in 2022. On 09-MAY-2022, the patient went to the hospital and was diagnosed with blood clot. The date of hospitalization and number of days hospitalized were not reported. On MAR-2023, the patient experienced COPD (Chronic obstructive pulmonary disease). Patient also reported that she was on oxygen 24 hours a day so she had to retire and she had nothing but troubles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clot, and sick, and the outcome of COPD and pulmonary hypertension was not reported. This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20230627259.; Sender's Comments: V0: 20230627296-blood clot. The event has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration. 20230627296-pulmonary hypertension. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.
Husband and wife both vaccinated on 02/05/2021 test positive for Covid 19.  Both had two doses of Pfizer lot EL128
Pt received flu shot in left arm. Pneumonia in Rt. At 5am morning after injections the pt experienced a paralyzed arm. Could move fingers but arms limp & really sore. Did not go to hospital because symptoms did not get worse. Daughter advised him. Symptoms resolved within following 2 days. He remarked that the shot was administered very high on the arm.
pt recvd vax; devel rectal t of 100.8; fine red rash on head; face; chest which was fading prior to being seen in er; was cranky; DPH given; cont apap; MD suspects viral infect
2/22/12 Patient came back to report that she experienced 72 hours of undue fatigue that began 24 hours after vaccinated. Complete recovery.
Day 1- Almost immediate response (<~5 minutes) Tingling R fingers ; tingling tongue; slight numbness R arm & slight facial numbness, metallic taste in mouth Later Day 1 afternoon and evening - heart palpitations; metallic taste in mouth.  Usual & expected solicited SEs: fatigue, soreness, feeling "off," transient headache, chills sx Day 2- strong R arm pain, cannot lift R arm.  Metallic taste in mouth and tingling tongue persists.  Also same usual Sx as day 1 plus mild nausea.   Felt really crummy.   Day 3- Still moderately strong R arm pain, can only partially lift arm over head, cannot straighten over head.   Strong fatigue continues, mild nausea.   By this day I recall having some unusual Noc . calf cramping.   Sx certainly improved after 72 hrs but some did continue up to 7 days.   Cramping returned as did odd R ear/jaw/throat nerve pain.  Scratchy throat.  Fatigue persisted, gradually improved.  I believe the non-standard SEs may represent an allergic reaction.  I deem this mild to moderate, as I was unable to perform daily functions at times.  I would like to be able to talk to a professional as to whether a second dose is recommended in my situation.  I am concerned to know if previous allergic reactions suggest increase likelihood of future and possibly worsened reactions.  Note: I have been unable to access my Vsafe reports today to confirm exact time frame.  The above is to best of my recollection.
At 4am the day following the shot I woke up diarrhea, vomiting, a fever (101.4), chills/sweating, squeezing chest pain, tightness in throat, swelling of hands/feet, joint pain and throbbing headache- by later in the day I had also developed a blister type rash on my upper butt crack.  I got the shot on Weds- symptoms finally subsided by Sunday evening except the rash which on Sunday had crusted over and is now/currently dark red, flat and feels sore/tingly.  I'm currently waiting  f or a return call from my doctors office about how to treat the rash.  This rash looks very similar to shingles.   My 18 yr old daughter got the shot one day before me and has this same rash on her cheek.
PT REPORTS DIFFICULTY BREATHING 2 HRS AFTER INJECTION.  SHINGLES RASH ON HIPS WITHIN 12 HRS OF INJECTION AND CONTINUES AT THIS TIME
Patient did not report any history of syncope with injections; stated she takes B-12 injection and injections for her migraine with no issues.  She received  the J&J vaccine at 3:41pm. Reported immediate arm soreness. While in the 15-min observation area at 3:45pm, patient fell out of chair onto the floor 2/2 LOC. I attended immediately to the patient (EMS was called at 3:47 due to LOC) When I arrived, patient was laying on her stomach and was awaking up. We turned her onto back and placed her feet in the air. Patient was immediately able to tell me her name and date of birth. She was given cold towels and she was cooled down. Initial vitals taken at 3:47p were 146/98, HR 66. EMS arrived at 4:02 and took vitals (BP=146/94, SPO2=99%). EMS stood the patient up and patient refused to go with EMS. Patient instructed to wait an additional 15 mins after EMS left. Patients left in care of boyfriend
Length 13cm by Width 15cm.  Redness warm to touch, limited range of motion to arm.  Treatment: Medrol dose pak, Allegra 180mg, cool compresses.  Return to office if no improvement.
Intussusception - symptoms started 11/5/08; confirmed by x-ray on 11/6/08; unable to reduce by air contrast and barium contrast; required air transport to tertiary hospital and subsequent surgery.  11/18/2008 D/C Summary recieved for DOS 11/17-19/2008 with Final DX:  Intussusception-ileocolic.  Pt initially presented with pain, moaning, vomiting and blood streaked stool. Pt presented to hospital from another facility following failed reduction of IS via air contrast barium enema. Again, uanable to reduce so taken to OR for Laparoscopic reduction. Pt tolerated well, diet advance and d/c 11/9/08.
I have been coughing all day. I did not have this side-effect on any previous days, just this 3rd day so far.; It's day 3 and the taste has gone away.; Starting the day after injection, in the morning, my tongue tasted like metal for 2 days (food and drink tasted normal- except salt tasted sweeter).; however, now my throat is unbearably sore; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0177) via an unspecified route of administration on 11May2021 at 18:00 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration on 18Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 11:00, a day after vaccination. In the morning the patient experienced like tongue tasted like metal for two days (food and drink tasted normal- except salt tasted sweeter). On 15May2021, the taste had gone away; however, the throat was unbearably sore. On 15May2021, the patient coughed all day. The patient did not have this side-effect on any previous days, but just on the third day after vaccination. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events tongue tasted like metal, sore throat and coughing were all recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
redness, warmth & itchiness, 5x8cm @ inj site, started 6 days p/inj;
Patient in order to be compliant and able to work at the hospital she is employed needs to receive two covid vaccinations and one booster.  She has received her first dose in the primary series in September 2022. She went to Pharmacy on January 18, 2023, to receive her second dose in the primary series. Per Patient, she explained to the pharmacist she was there to receive her second covid booster in the primary series although she did not have her card only one dose (September 2022) was listed in the system.  The pharmacist then told Patient they only had Moderna Bivalent there and that she was ok to receive that vaccination as her second dose in the primary series.
Patient received expired Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient received first booster dose.  Concomitant drugs were not reported. Treatment medications were not provided.  It was reported that it was unknown if the vial was stored in refrigerator and no temperature did occur.   This case was linked to MOD-2022-538058 (Patient Link).
Myalgia, Hypertonia, Arthritis, Arthalgia, Paraesthesia, Carpal tunnel syndrome, Myofascitis  This case was reported by french regional center of pharmacovigilance, via another manufacturer (Sanofi Pasteur MSD) and described the occurrence of muscle pain in a 34-year-old female subject who was vaccinated with hepatitis B vaccine (manufacturer unspecified) for prophylaxis.  The subject belongs to the EMMM association number 235.  In 1999, the subject received an unspecified dose of hepatitis B vaccine (batch number not available).  Since October 2003, three years after vaccination with hepatitis B vaccine, the subject developed muscle pain an dhypertonia at the four limbs level, joint inflammation with incapacity to carry a weight, bilateral hip pain.  The subject presented with difficulty to stay sitting down and laying down.  As well, she had tingling in limbs, joint pain, carpal tunnel pain (more painful at the right side).  On 16 December 2005, fascia biopsy showed lesions of macrophagic myofascitis.  Left deltoid muscle biopsy was normal.  At the time of reporting the outcome of the events were was unspecified.  The reporter's causality assessment was unknown.  On 16 December 2005, fascia biopsy showed lesions of macrophagic myofascitis.  Left deltoid muscle biopsy was normal.   LABORATORY TEST NAME, TEST DATE, TEST RESULT, LOW NORMAL, HIGH NORMAL Biopsy muscle, 16Dec2005, Abnormal
cough; sore throat; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), OROPHARYNGEAL PAIN (sore throat), FATIGUE (Fatigue) and PYREXIA (Fever) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. o26a21a) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced FATIGUE (Fatigue). On 13-Mar-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced COUGH (cough) and OROPHARYNGEAL PAIN (sore throat). On 14-Mar-2021, PYREXIA (Fever) had resolved. On 16-Mar-2021, FATIGUE (Fatigue) had resolved. At the time of the report, COUGH (cough) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified high blood pressure medications. The patient had a sleep as treatment.
After nothing occurred x 30 minutes post vaccine, Attendee suddenly became limp, stiffened body and convulsed. Was placed on cit, in recovery position, vital signs checked (stable) and EMS were called.  Close monitoring and 2nd set of vital signs. Mother of Attendee was close by at all times.  Attendee was awake, answered question appropriately, but slow speech - seemed post ictal.  EMS arrived after 10 minutes and transported Attendee to local hospital.
This spontaneous report as received from a a health worker refers to a 13 weeks old patient. The patient was in the office to receive with a first dose of live, oral ROTATEQ (dose and lot number not provided) on 21-NOV-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. It was unspecified if the patient had sought medical attention. Additional information is not expected.
Approx. 5-10 minutes following influenza vaccine injection as pt was leaving in the hallway, mother brought pt back to clinic area with skin flushing and coughing. Pt states she feels itchy. Taken back to room for assessment. Pt coughing hard, tries to vomit, facial cheeks, arms and upper chest reddened. Area around mouth pale white in color, no shortness of breath, pt alert, orientated and able to speak. Dr. aware and orders Benadryl 25mg IM stat. Administered in right thigh IM as ordered. Pt calming down, less coughing, breathing normally, rests on bed with cool cloth on forehead, moth at bedside. Pt reports she is feeling better. Monitored by Dr. and nurse and pt released after feeling better with no further symptoms of reaction. Strep test positive today. Mother aware to give Benadryl 25mg po or Zyrtec 10mg po if pt begins to have rash again. She is to bring pt back to clinic if concerned. She states agreement.
One week after 2nd dose, developed extreme fatigue, numbness and weakness in both legs, aching/pain in legs, loss of feeling in feet and occasional pins and needles feeling in feet.  Some numbness/tingling in hands as well.  Difficulty walking, just needs to sit.  Difficulty raising arms.  Complaints of legs and arms feeling very heavy.  Shortness of breath.
It started with pain at the injection sight and then I was sore all over my left side and back. I then got chills and could not get warm and later woke up to a fever of 103 F, nausea, and a migraine headache. I took Aleve that brought my fever down to 101.5F. I have continued to have there symptoms and other flu like symptoms.
it was warm to the touch; arm was sore and red for 3 days/it started getting very tender and sore; arm was sore and red for 3 days/red spot where I got the injection; This spontaneous case was reported by a medical assistant (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (it was warm to the touch), VACCINATION SITE PAIN (arm was sore and red for 3 days/it started getting very tender and sore) and VACCINATION SITE ERYTHEMA (arm was sore and red for 3 days/red spot where I got the injection) in a 36-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE PAIN (arm was sore and red for 3 days/it started getting very tender and sore) and VACCINATION SITE ERYTHEMA (arm was sore and red for 3 days/red spot where I got the injection). On 07-Jan-2021, the patient experienced VACCINATION SITE WARMTH (it was warm to the touch). On 01-Jan-2021, VACCINATION SITE PAIN (arm was sore and red for 3 days/it started getting very tender and sore) and VACCINATION SITE ERYTHEMA (arm was sore and red for 3 days/red spot where I got the injection) had resolved. At the time of the report, VACCINATION SITE WARMTH (it was warm to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
A single hive approx 2cm x 3cm appeared distal to PROQUAD injection site within approx 1 minute of injection. Denies trouble breathing or a "tickle" in her throat. Denies itching. Went away approx 2 hours.
2 days, post vax, noticed large red, hot and swollen area at site with a hardened lump. Not painful. MD recommended hot packs and thought it probably was not an allergic reaction but local reaction that was due to shot being put in posterior/lateral arm versus deltoid.
mom called clinic & stated pt had high pitched scream that nothing mom did would relieve it; also pt had only taken 4oz of formula total for today; no temp; just high pitched scream & dec appetite;
Patient hospitalized for CHF (congestive heart failure), NYHA class IV, acute on chronic, diastolic within 6 weeks of receiving COVID vaccination.
Patient received Prevnar 13 on 11/29/19 in right deltoid muscle.  She had soreness that day and developed a rash/redness on skin in the middle of the arm.  Patient had soreness and redness which continued to persist.  Patient came to pharmacy on Sunday and pharmacist saw redness on arm and referred her to primary care.   Patient saw her primary care on 12/9/19 for another reason and asked her primary care about the red patch.  Her primary care gave her Augmentin 500 bid along with cough medication.  Patient came to pharmacy on Monday.   She showed me her arm with redness.  She said her redness was less at that time.  Today, 12/10/19, her husband came to pharmacy and told me her arm was more red and it was sore when she lifted her arm.  I contacted oversight physician, Dr. Dr. said it may be cellulitits and antibiotic may make a difference.  I contacted her primary care dr. and she asked that patient should continue on Augmentin.  Patient is to follow up in a week.
Initial report received from another manufacturer on 29 October 2008 who received the report from a health care professional. A female patient (age not reported) developed reactive pericarditis after receiving an unspecified influenza vaccine. The date of the vaccine administration and the date of onset of symptoms were not specified. No additional details were reported. Documents held by sender: None  11/21/08 Reviewed Pulmo records received from CDC. FINAL DX: COPD Records reveal patient had been hospitalized 12/2002 w/pleural effusion secondary to flu shot & was seen in office 8/9/2003.  Had thoracentesis in hospital that was non-diagnostic.  Cardiac w/u neg.  Had continued SOB.  Ex-smoker who quit 12/2002.  CXR c/w COPD.  Tx w/inhalers.
Anaphylactic reaction that developed at 12:30 am on night of receiving dose.
Syncopal episode post vaccine (approximately 30 minutes post vaccine) patient had no recall of episode Vital signs and  & B/P WNL Cardiac strip - Inverted T-waves(by paramedics) local Squad notified - client transported to hospital
patient briefly passed out but did not fall. was responsive and was conscious. only occured within 5 minute span or less and she was fine after and left on her own after 30 minutes
This case was reported by a pharmacist via call center representative and described the occurrence of fatigue in a 64-year-old female patient who received SHINGRIX (batch number CH2X7, expiry date 25th April 2020) for prophylaxis. On 7th May 2018, the patient received the 1st dose of SHINGRIX. On 7th May 2018, less than a day after receiving SHINGRIX, the patient experienced fatigue, general body pain and shivering. On 9th May 2018, the outcome of the fatigue, general body pain and shivering were recovered/resolved. It was unknown if the reporter considered the fatigue, general body pain and shivering to be related to SHINGRIX. Additional details were reported as follows: The patient experienced fatigue, shivering and body aches. No further information was provided by the healthcare professional.
Bronchitis; lot of congestion in her chest; cough; small fever; This is a spontaneous case received from a contactable consumer (patient) via Pfizer-sponsored program. A 93-year-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/batch number was not reported), via an unspecified route of administration on 12Feb2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced bronchitis, lot of congestion in her chest, cough and fever. Therapeutic measures were taken as a result of the event (lot of congestion in her chest) and included treatment with "Z-pack" therapy. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.